Is First Trust Nasdaq Pharmaceuticals ETF (FTXH) a Buy, Sell, or Hold?
NASDAQ : FTXH
First Trust Nasdaq Pharmaceuticals ETF — News
$39.9811 USD
$0.07 (0.18%)
- Volume
- 62.42K
- Average Volume
- 561.73K
- Market Capitalization
- $989.49M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $42.87
- Year Low
- $27.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
| Source | Headline |
|---|---|
|
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now?
The First Trust NASDAQ Pharmaceuticals ETF (FTXH) was launched on 09/20/2016, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. zacks.com - 2026-08-06 07:21:12 |
|
Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the First Trust NASDAQ Pharmaceuticals ETF (FTXH) is a passively managed exchange traded fund launched on September 20, 2016. zacks.com - 2026-07-30 07:21:07 |
|
Trump to announce discount drug pricing expansion, White House official says
U.S. President Donald Trump will announce a dramatic expansion of TrumpRx.gov, a government-backed website offering discounted prescription drugs under his administration's pricing deal, on Monday, a White House official said. reuters.com - 2026-05-18 12:47:12 |
